The aim of the present study was t o determine if the human erythroid (E) and megakaryocytic (MK) lineages were closely linked to the existence of a bipotent burst-forming unit (BFU) E/MK progenitor. In methylcellulose cultures, BFU-E/MK colonies were observed at day 12 and closely resembled mature BFU-E with the exception that the erythroid component was surrounded by MK. These colonies were quite different from the colony forming unit (CFU)-GEMM-derived colonies, which were composed of a larger number of erythroblasts and which developed later in culture. The existence of these bilineage colonies composed of 100 t o 1,000 erythroblasts intermingled with a few MK and without granulocytic cells was confirmed by the plasma clot technique and immunoalkaline phosphatase labeling of the MK. To investigate if this bipotent progenitor belonged to the compartment of primitive progenitors, CD34' marrow cells were subfractionated according t o expression of the CD38 antigen. The bipotent BFU-E/MK progenitor as well as a large fraction of MK progenitors were found in the CD34+ CD38' or in the CD34' CD38-cell fractions. Growth of this bipotent BFU-E/MK progenitor required the combination of stem cell factor (SCF), interleukin-3 (IL-3). and Epo in serum free conditions. Addition of IL-6 had only a marginal effect, whereas megakaryocyte growth and development factor (MGDF) was not an absolute requirement, but slightly increased the plating ef-HE HEMATOPOIETIC system is composed of heterogenous populations of cells that have been schematically divided into three compartments,' ie, a stem cell, a progenitor cell, and a terminally differentiating cell compartment. Regulation of cell proliferation and differentiation in the progenitor compartment is mainly controlled by identified cytokines, but molecular mechanisms involved in the commitment of a pluripotent stem cell toward one cell lineage are presently unknown. Several lines of evidence, most of them based on the analysis of the composition of colony forming unit (CFU)-S or of the progeny of paired daughter suggest that decisions at the level of early stem cells are stochastic. However, whether the restriction of stem cells potential occurs progressively through the production of intermediate oligopotent progenitors with all the various combinations of potentialities or only after one division with the generation of only monopotent progenitors is still Clonal 0006-4971/96/8804-0017$3.00/0 1284 ficiency of CFU-MK and of BFU-E/MK progenitors when combined with SCF, IL-3. and Epo. In contrast, when these cultures were performed in the presence of 30% fetal calf serum, no BFU-E/MK colonies were observed irrespective of the combination of growth factors used, including the presence of MGDF; however, inclusion of the MS-5 cell line restored the growth of this bipotent progenitor. In contrast, in cultures performed in the presence of human normal or aplastic plasma, MS-5 had only a slight effect on the cloning efficiency but improved MK cytoplasmic maturation and MK size, suggesting that the main effect of MS-5 is t o diminish the inhibitory effect of the fetal calf serum on the MK differentiation. The clonal origin of bipotent BFU-E/MK colonies was demonstrated in liquid culture of single CD34' CD38'OW cells by immunophenotyping individual clones. At day 12,
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MATERIALS AND METHODS

Bone Marrow Cells
Bone marrow was obtained from patients undergoing hip surgery after informed consent was obtained in accordance with the institutional guidelines of the Committee on Human Investigation. Cells were collected by vigorous shaking of bone fragments in Iscove's modified Dulbecco's medium (IMDM, GIBCO, Paisley, Scotland), supplemented with 100 pg/& of deoxyribonuclease (DNase t y p I; Sigma, St Louis, MO), centrifuged once, counted, and separated on Ficoll-Hypaque (Seromed, Berlin, Germany). Light-density (< 1.077 g/mL) marrow cells (LDMC) were recovered and after washing were used either for isolation of CD34+ cells by the immunomagnetic bead technique or flow cytometry.
Antibodies
Fl'K-a~~ti-ClXl (anti-GpIIbm Immunotech, Luminy, Fran~e), FITC-anti-CD61 (GpIUa; Dako, Glostrup, Denmark), FITC-antiglycophorin A (GPA) (Dako), R-PE anti-GPA (Immunotech), FITCanti-CD15 (Lewis", granulocytic and monocytic differentiation, Dako), FITC anti-CD38 (IOB6) (Immunotech), FITC-CDllb (Mac-1, granulocytic and monocytic differentiation, Immunotech), FITCanti-HLA-DR (Immunotech), R-PE anti-CD41 (Dako), R-PE-HPCA-2 (CD34; Becton Dickinson, Mountain View, CA), and R-PE anti-CD14 (Gp55, granulocytic and monocytic differentiation, Becton Dickinson) were used either for cell sorting or analysis by flow cytometry. The unconjugated antibody Y2/51 (anti-CD61) was a generous gift from Dr D. Mason (Oxford, UK).
Isolation of CD34 by the Immunomagnetic Bead Technique
CD34+ cells were recovered from LDMC (2 X 10' cells) by the immunomagnetic bead technique using the Dynal kit (Dynabeads M450 CD34) according to the manufacturer's instructions (Dynal, Oslo, Norway). CD34+ cells were detached from the beads using the DETACHa BEAD solution (Dynal).
Cell Sorting
Subpopulations of CD34+ cells were sorted according to their expression of the CD38 antigen starting from LDMC or magnetic bead isolated CD34+ cells. Cells were incubated simultaneously with the R-PE- 
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HPCA-2 (CD34) and FITC-IOB6 (CD38
Assessment of Hematopoietic Progenitor Cells
Quantitation of clonogenicprogenitors insemi-solidassays. Erythroid (CFU-E and mature and immature BFU-E), granulocytic (CFU-GM), megakaryocytic (CFU-MK), and mixed (CFU-GE") progenitors were quantified using previously described methylcellulose assays?' Each cellular fraction selected was plated at a concentration of 0.5 to 2 X lo3 cells/mL of complete methylcellulose medium (0.8% methylcellulose in IMDM, 30% fetal calf serum FCS], 1% deionized bovine serum albumin PSA] and iO-4 mom 0-mercaptoethanol). Cultures were also performed in the presence of sera from aplastic patients or in serum-free medium as previously rep~rted.'~ Briefly, the medium contained 1.5% deionized senim albumin (Cohn fraction V Sigma Chemical CO), iron saturated human transferrin (300 p g / a , Sigma), calcium chloride (28 ng/&), a mixture of sonicated lipids, 7.5 X lO-4 mom, cy-thioglycerol, 100 ng/mL insulin, and 0.8% chemically pure methylcellulose in IMDM. The lipid mixture was produced by sonicating 7.8 mg cholesterol, 6.14 mg oleic acid, and 7.4 mg dipalmitoyl lecithin (all obtained from Sigma) in 10 mL of IMDM (without sodium bicarbonate) containing 1% albumin. Aliquots (20 pUmL) of this mixture were added to the culture medium. Colony-stimulating factors were provided either as agar-leukocyte conditioned medium (agar-LCM: 10% vollvol) or as recombinant human (rh) growth factors: rhStem cell factor (SCF) (S0 ng/mL). G-CSF (20 nglmL). and megakaryocyte growth and development factor (MGDF) (10 nglmL) also called Mpl-ligand (Mpl-L), or thrombopoietin (TPO) (all three kindly provided by AMGEN, Thousand Oaks, CA), rhIL-6 (100 U/mL). rhIL-3 (100 UlmL), rhGM-CSF (2 ng/mL) (kindly provided by Immunex. Seattle, WA) and human erythropoietin (rhEpo: I UlmL; Amersham). Petri dishes were cultured at 37°C in a S 8 C0?-9S% air humidified incubator. Hematopoietic progenitors were scored at least twice at days 12 to 14 and 20 to 25.
Cultures were also performed by the plasma clot technique using either serum from aplastic patients (AP) or FCS or serum from platelet poor plasma (PPP) and a combination of cytokines." When MGDF became available, cultures were performed by the serumfree fibrin clot.'5 Briefly, ingredients for serum-free cultures were the same as for methylcellulose cultures with the bovine citrated plasma being replaced by bovine plasma fibrinogen ( I mglmL. Sigma), 0.01 m o l L e amino caproic acid, and horse thrombin (6 mUlmL, Stago). Cultures were incubated as described above and studied after 12 days. Colonies were quantified by an indirect immunophosphatase alkaline labeling technique using an anti-GplIIa MoAb (CDhl, Y2-S I ). Dishes were scanned completely under an inverted microscope at 40 or 100 X magnification.
We have previously reported that addition of murine stromal cells from the MS-S cell line to hematopoietic colony assays selectively stimulates the expression of very early clonogenic progenitor cells (immature RFU-E. CFU-GEMM) in synergy with growth factors.'" The MS-S stromal cell line" was kindly provided by K. Mori and maintained in CYMEM supplemented with 10% FCS. Its growthpromoting effect was assessed by adding 10.000 MS-S cells to both methylcellulose and plasma clot assays.
Single cell cdnrres. In limiting dilution experiments. individual CD34* CD38'"" were sorted into 96-well plates using serum-free medium and a combination of seven cytokines (SCF. IL-3. Epo. IL-6 , G-CSF, GM-CSF. and MGDF) or of AP and six cytokines (all except MGDF). Plates were examined at day I I to 13. day 18 to 20. and later after incubation at 37°C in an air atmosphere supplemented with S 8 CO:. Individual clones were cytocentrifuged or divided into two parts for flow cytometric analysis. The first half was doubly labeled with
Exp 2 For personal use only. on October 3, 2017. by guest www.bloodjournal.org From R-PE anti-CD41a and FlTC anti-GPA MoAb or FlTC anti-CD41 and R-PE anti-GPA. The second half was labeled with R-PE anti-CD14 and FlTC anti-CD15 or FlTC anti-CD1 lb. Cells were analyzed on a FACS sort. Ulrrustnrcrrrrul srrrdies. Cultured cells were studied by electron microscopy (EM). They were washed twice in Hank's medium at 4"C, fixed with 1.2S% glutaraldehyde in Gey's buffer for IO minutes." washed, and incubated in diaminobenzidine medium.'" Cells were then post-fixed with osmium tetroxide. dehydrated. and embedded in epon. Thin sections were examined with a Philips CM IO electron microscope (Philips. Eindoven, Netherlands) after lead citrate staining.
RESULTS
Ident$cation qf a Bipotent Enthroin-Megnkonoc?.tic (BFU-ELWK) Progenitor Cell
In preliminary experiments aimed at optimizing culture conditions for the growth of marrow-derived CD34-/CD38-primitive progenitors in methylcellulose, we observed that the addition of the murine MS-S stromal cell line to the
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A% assay synergized with added human cytokines (see below) to promote the development of primitive progenitors." Of note. we observed that at early time points (day 12) during the culture a fraction of small (<l00 cells) hemoglobinized colonies contained MK (Fig 1 A) . The erythroid compartment of these colonies was similar in size and time required for maturation to that of mature BFU-E-derived colonies.3" Some typical colonies were studied by morphology and only contained E and MK cells. These progenitors were easily distinguished from standard CFU-GEMM and primitive BFU-E both by the size of the colonies generated and by the time (> 18 to 20 days) required for their differentiation. These progenitors were also identified in plasma-clot assays ( Fig IB) and the presence of MK in these mixed colonies was confirmed by immunolabeling with an anti-CD41 or an anti-CD61 MoAb. Usually 2 to 30 MK were counted together with 500 to 1.000 erythroblasts. No other cell type was detected by morphologic criteria. These colonies were not a simple overlap of two types of colonies since they were still observed at low cell concentration where even a single colony was grown. This result was confirmed by single cell assay (see below). These progenitors were desigIn another series of experiments, we precisely defined the properties of this progenitor cell with respect to its CD34/ CD38 phenotype and response to cytokines. We also tried to define its place in the hierarchy of hematopoietic progenitor cells by investigating if this bilineage association was purely random or reflects a preferential association between
Day 20
nated BFU-E/MK.
*% E and MK differentiation. 
and cells expressing lower levels of the CD38 antigen
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From (CD38'""). This last subpopulation was very heterogeneous including CD38 negative (CD38-, 10% of the CD34-cells) cells that fell within the limits defined by control IgG, and CD38' cells (20% of the CD34' cells), although the limit between these two populations was empirical. These three subpopulations, CD34'/CD38', CD34'/CD38', and CD34'/CD38-, were sorted and analyzed for their content in BFU-EIMK progenitors, simultaneously in plasma clot and methylcellulose assays.
As shown in Table 1 and Fig 2, BFU-EIMK identified in plasma clot and methylcellulose assays were present in the CD34'/CD38' or CD34'/CD38-fraction and were not found in the CD38' fraction. This contrasted with the distribution of mature BFU-E, 90% of which were detected in the CD38' fraction, an observation that fits with previous observations showing that expression of CD38 discriminates between mature (CD38-) and immature (CD38'""') progenitor cells." If one considers as a single category colonies hemoglobinized at days 10 to 12, a significant proportion of these (19% to 60%) contained MK, whereas mature BFU-E-derived colonies scored in assays initiated with CD38' cells were exclusively erythroid. There was some variability in the frequency of the BFU-EIMK-derived colonies among CD38-and CD38' cells. In some, the BFU-E/MK progenitors were predominantly in the CD38". whereas in others they were found in the CD38-cell fraction (Fig 2) . Although immature BFU-E (imBFU-E) were enriched in the CD.38-and CD38' cell fraction, approximately 40% of them were contained in the CD38-cell fraction. Therefore, taking into account only the expression of the CD38 antigen, BFU-E/ MK appears more immature than the imBFU-E. In plasma clot and methylcellulose, MK progenitors were also enriched in the CD34' CD38'""' cell population with significant heterogeneity in the size of the colonies (from 3 to more than 100 MK). In the CD34' CD38-cell fraction, 30% to 50% of the MK colonies were bipotent. In contrast, in the CD34' CD38' cell fraction MK progenitors gave rise to pure MK colonies.
Kinetics of development of MK-containing progenitors were next analyzed in plasma clot assays. As shown in Fig  3, the kinetics of BFU-WMK and CFU-MK were comparable. MK colonies were the first colonies to be recognized. and at day 7 of culture, MK colonies were almost the only type of hematopoietic colonies present with some colonies containing up to 50 MK. CFU-MK were counted at day I2 and contained up to a few hundred MK. BFU-WMK-derived colonies developed with very similar kinetics: they were first detected at day 7 of culture and their number was maximum at about day 12. Although the absolute number of BFU-WMK-derived colonies was low, these mixed colonies represented up to 60% of the total number of pooled MK and E colonies. At day 18 of culture, CFU-MK-and BFU-WMK-derived colonies were still present but began to lyse and were not detected after day 20. In contrast. large E colonies that included granulocytes, monocytes, and more rarely MK were detected at this time. By day 18. in methylcellulose cultures, lysing BFU-EIMK colonies and growing CFU-GEMM-derived colonies were observed in the same dish, but they clearly corresponded to two distinct types of colonies.
Single Cell Cdtlrres
The existence of a bipotent BFU-E/MK progenitor was clearly established in single cell cultures. Furthermore, this approach also allowed us to validate previous observations, which suggests that even late in differentiation the E and MK programs are preferentially associated. CD34'/CD38'"" cells from five different bone marrows were directly sorted into wells of 96-well microtiter plates. After sorting, we checked that a single cell was present in more than 95% of the wells. Five hundred wells were initiated per experiment in IMDM supplemented in three experiments with 10% AP and a combination of six cytokines (SCF, Epo, IL-3, GM-CSF, G-CSF, and IL-6) and in the other two in serum-free medium supplemented with the same cytokines plus MGDF. This combination of cytokines was chosen to ensure optimal differentiation in E, MK and granulo/macrophagic pathway. Cultures were studied after I O to 12, 18 to 20, and in two experiments after 30 days at 37°C 5% COz. Clones were selected that contained at least 100 cells and only those were analyzed. Those represented 8% 2 2% and 20% 1-6% of the initial wells at days 12 and 20, respectively. In a preliminary experiment, individual clones were pipetted off, cytocentrifuged. and morphologically analyzed. However. this procedure resulted in partial loss of MK during cytocentrifugation, and in subsequent experiments clones were analyzed by flow cytometry. Each clone was divided into two equal cell fractions. Part of the cells was labeled simultaneously with antibodies against GPA and either CD61 or CD41 and the other half with antibodies directed against CD14 and either CD15 or CD1 1 b. Under these conditions, at day 12. 61 56 of the 93 analyzed clones contained some erythroblasts (ranging from 15% to 100% of the total population) and thus arose For personal use only. on October 3, 2017. by guest www.bloodjournal.org From from a progenitor capable of erythroid differentiation (Fig  4) . Twenty-one percent of the clones (pooled experiments) contained only GPA+ cells, while 30% of the clones contained both GPA' cells and cells highly labeled with the antibodies against the CD61 or CD41 antigen (Fig 5) . These cells positive for MK markers had high forward and side scatter properties characteristic of cultured MK, which allow easy discrimination between erythroblasts and MK on the basis of light scatter properties. In all these clones, GPA+ cells represent more than 85% and MK 1% to 8% of the events analyzed (Fig 5) . None of the cells present in these clones expressed granulocytic markers (CD14 and CD15). Clones containing granulocytes and MK without erythroblasts or granulocytes and erythroblasts without MK were also observed but at a low frequency (3% and 4%, respectively). Since we selected only wells containing over 100 cells, pure small MK clones could not be detected by flow cytometry. However, these were detected by microscopic observation and their MK nature was further documented by CD41 immunolabeling (data not shown).
At day 18 to 20 of culture, 20% of the total number of wells contained more than 100 cells and 56% of the 91 analyzed clones contained cells that expressed either CD14 or CD15 or both. A minority of the clones (8%) only contained GPA' cells. BFU-E/MK clones were also uncommon (5%) with very few MK (<2%). In contrast, clones containing GPA+, CD14+, CD15+, and CD41+ cells were much more frequent (22%) suggesting that they were derived from CFU-GEMM. These clones contained on average 5-fold more cells than those studied at day 12. Later in culture (around day 30), all the clones analyzed contained CD14' and CD15' cells but no GPA' or CD41+ cells.
Two BFU-E/MK clones identified at day 12 were subsequently studied at day 18, and no granulocytic cells could be detected.
Dejnition of Optimal Conditions for the Detection of BFU-E/MK Progenitors
The BFU-E/MK requirement for cytokines was first assessed in plasma clot cultures, which are optimized for the expression of MK differentiation. Cultures were ended at days 10 to 12 and stained with an anti-CD61 MoAb as 
Effect of the Addition of MS-5 Cells on the Growth of Different Types of Progenitor Cells in Methylcellulose Assays
Progenitor Cells per 1,000 CD34+/CD38'"" Cells For personal use only. on October 3, 2017. by guest www.bloodjournal.org From described. 32 In a first set of experiments performed before the cloning of MGDF (MpI-L, TPO), we compared the effect of normal human and aplastic human plasma on the development of CD34+/CD38low (including both CD38-and CD38'). In the presence of normal plasma, the growth of BFU-E/MK and CFU-MK was optimum in the presence of the combination of SCF, IL-3, and Epo with 4 ? 1.4 BFU-E N K per 1,000 cells, and 6 5 2.8 CFU-MK per 1,000 cells. Similar results were found with AP, but cloning efficiency was slightly higher ( 5 ? 1.4 BFU-E/MK per 1,000 cells, and 9.5 2 1.9 CFU-MK per 1,000 cells). In a second set of experiments, we tested the effect of MGDF in serum free conditions (Table 2) . Best results were obtained when MGDF was added to SCF, IL-3, Epo with 13 to 17 BFU-E/ MK per 1,000 CD34+/CD3g1"" (including CD38-+ CD38') cells, and 25 to 27 CFU-MK, whereas only six BFU-E/MK progenitors were observed without MGDF. Withdrawal of either IL-3 or SCF even though high concentrations of MGDF were kept constant decreased the number of BFU-E/MK progenitors, but not of CFU-MK, which fits well with the known requirement of either IL-3 or SCF for the proliferation of early E cells. Addition of IL-6 either to a combination of three (SCF, IL-3, Epo) or four (the same three + MGDF) did not further increase plating efficiency. Precise quantitation of the E compartment was hampered in plasma clots by the early termination required for MK quantification.
Methylcellulose assays were also performed with CD34' CD38'"" cells in the presence of 30% FCS, a concentration that is optimum for E development but selectively inhibits MK d e~e l o p m e n t ?~.~~ Addition of A-LCM or the combination of SCF, IL-3, and Epo and even MGDF did not neutralize this inhibition. In contrast, the addition of MS-5 cells to the assay (independently of the cytokine combination) dramatically counteracted FCS effect both on CFU-MK and BFU-E/MK (Table 3 and Fig IC) . Thus, on average eight CFU-MK were scored per 1,000 CD34+/CD38'"" cells (Table l). Most interestingly, even though the total number of small E colonies scored as mBFU-E in the CD38loW fraction did not change when MS-5 cells were added (Table 3) , 20% to 25% of these now clearly included MK, which suggests that a proportion of E progenitors were in fact not restricted to the erythroid lineage. The observation that 90% of the mBFU-E are in the CD38+ fraction and generate only E cells independently of the presence of MS-5 cells reinforced the idea that the BFU-E/MK progenitor represents a unique step in the hierarchy of progenitors. However, expression of the MK potential requires specific conditions, and in the absence of MS-5 cells, this progenitor would be scored as a mature BFU-E only capable of differentiating along the E pathway.
Of note is the fact that MS-5 cells also increased the size of MKS suggesting that they may also act on MK terminal differentiation (see EM studies below).
In contrast to their lack of proliferative effect on small E colonies, the number and size of which did not change ( Table  1 and ref 26) , MS-5 cells stimulated the proliferation of immature BFU-E and CFU-GEMM as 20 to 30 of these progenitors were detected per 1,000 CD34+ CD38-cells, but almost none in the absence of MS-5 cells (Table 3) .
Similar results were observed in plasma clot, after immunolabeling. BFU-E/MK and pure MK colonies were absent when cultures contained 30% FCS. MK differentiation was observed when MS-5 cells were added.
Ultrastructural studies confirmed the action of MS-5 cells in promoting terminal MK maturation. For these studies, purified CD34+/CD38Io" cells were cultured for 7 to 10 days in liquid medium in the presence of MS-5 cells plus AP with or without SCF and IL-3 and studied by EM. These cultures were compared with control cultures performed in the absence of MS-5. In 10 distinct experiments, MK differentiation occured in close contact with MS-5 (Fig 6) . MK were generally surrounded by MS-5 in a rosette-like shape. In the areas of contact with MS-5. MK developed numerous blebs that were absent outside this zone. Contacts between the two membranes were very tight but without junction. In some rosettes, MS-5 cells extended their pseudopods between each bleb. The quality of maturation was equivalent to that observed in vivo with the regular distribution of demarcation membranes and a-granules. No such degree of maturity was observed in control cultures (without MS-5). Adhesion between MK and MS-5 cells occurred very early during maturation since small promegakaryoblasts with large nucleoli were associated with MS-S cells. No such intimate contacts were seen with cells from other lineages, granulocyte or erythroblastic.
Cell Cycle Status of the BFU-E/MK Progenitor
Results from the experiments described above suggest that BFU-E/MK progenitors are more immature than the CD38+ E-restricted progenitors based on their lack of expression of CD38 and ability to differentiate into two lineages. A third indicator of primitiveness is quiescence.6 In this series of experiments, we determined the cell cycle status of BFU-E/MK by three-color labeling using R-PE anti-CD34 MoAb, FITC anti-CD38 MoAb, and Hoechst dye as shown in Fig 7A and B . In an attempt to increase the sensitivity of the procedure and detect subpopulations within the GO/GI population, which may correspond to more primitive populations, incubation with the Hoechst Hoechst'"", GOIG1, and SIGZIM. Of note, cycling cells are essentially in the CD38' cell fractions, whereas Hoechst'"" cells are in the CD38'"" cell fraction. stain was shortened, whereas usually 2 hours is required to reach the equilibrum. With this procedure, three CD34' populations were identified, Hoechst', which may identify more primitive progenitors,'5 Hoechst" (2n), and Hoechst" (S/G2/M) (Fig 7, B and C) . There was a clear correlation between the expression of CD38 and the uptake of the Hoechst dye (Fig 7B) . Among the CD38'""' subset, all cells were Hoechst' or Hoechst' and only 1% to 4% of the cells were in the Hoechst" (S/G2/M) fraction. In contrast, 10% to 15% of the CD38' cells was in the S/G2/ M phase. Since a similarly low proportion of CD38'"" cells was in the S/G2/M phase when the Hoechst staining period was prolonged for 2 hours, the number of cycling cells was not underestimated. In addition, this result is in agreement with a recent report using propidium iodide to stain DNA." Cell sorting experiments were held in which CD34' CD38-Hoechst'"", CD34' CD38-Hoechst' (GO/ GI), and CD34' CD38-Hoechst" (S/G2/M) cells were assayed for their content in progenitors. The results showed that most BFU-E/MK progenitors were in the Hoechst' or Hoechst' fractions and only 0.32% and 0.95% of BFU-E/ MK and CFU-MK of the CD38'""' population were in the S/G2/M phase of the cell cycle, respectively. Cloning efficiency of BFU-E/MK was much higher in the CD34' CD38-GO/GI cell population than in the two other cell fractions (1.2% versus 0.28% and 0.25%) (Fig 8) . Further functional analysis of these different Hoechst fractions for their content of other clonogenic progenitors of varying maturity showed that 20% of the mBFU-E contained in the CD38' cell fraction were in the S/G2/M phase of the cell cycle. In contrast, only 1.2% of the mBFU-E and less than 0.5% of the CFU-GEMM contained in the CD38-cell fraction were in S phase.
DISCUSSION
Observations of mixed' MK-E bursts in mice" and also in humans'" have provided the initial basis suggesting the For personal use only. on October 3, 2017. by guest www.bloodjournal.org From existence of a bipotent progenitor restricted to both MK and E lineages. Further studies have suggested that divergence of both lineages was a late event in the hierarchy of stem cell differentiation4 although no direct evidence supported this hypothesis. Since then, considerable evidence in support of such a common pathway has been obtained from studies that showed that several transcription factors such as GATA-1, Tal-1, and NFE-2 are shared by both lineages. l4,l6 Detailed data on the phenotype and growth properties of this bipotent progenitor are lacking partly because most of the studies were performed before the isolation of the different hematopoietic growth factors and the development of cell purification techniques. Since then further similarities in the response to Epo and MGDF of committed progenitors from both lineages and shared expression of Epo-R also strengthened the hypothesis. In this study we provide strong evidence that a bipotent MK-E burst exists in human marrow, which can be distinguished from its more mature progeny, CFU-MK and mature BFU-E and also from its immature ancestor CFU-GEMM, by its phenotype, cell-cycle status, and cytokine response.
If one assumes that colony size and time taken to generate erythroblasts and mature MK both reflect the state of differentiation of the progenitor, BFU-E/MK appeared to be closer to mature BFU-E than to immature BFU-E or CFU-GEMM, based on the fact that mixed colonies were small containing at most 1,000 erythroblasts and a variable number of MK from 2 to 30."' The number of BFU-E/MK was maximal after a period of 12 days in culture and colonies lysed a few days later. In contrast, 16 to 18 days must elapse before primitive BFU-E and CFU-GEMM can express their full potential and complete differentiation. If the kinetics of colony formation classifies BFU-E/MK as close to mBFU-E, they differ from these both by their phenotype and cell cycle status. In contrast to day 12 BFU-E, 90% of which express both CD34 and CD38 antigens, BFU-E/MK were in the CD34' CD38'"" (either CD38' or CD38-) fraction and the great majority ( S O % ) of BFU-E/MK were in GO/G1 phase of the cell cycle, two properties that usually characterize immature progenitors.".." Noteworthy, this was also true for a fraction of CFU-MK, therefore suggesting that CD38 may not be expressed by cells of the megakaryocytic lineage to the same extent as on other myeloid precursors.
Definite proof that the potential of BFU-E/MK was restricted to E and MK lineages only was obtained in single cell experiments. The frequency of BFU-E/MK was estimated from the proportion of wells that contained more than 100 cells and only GPA' and CD41' cells after 12 days in culture. An estimated 2% to 3% of total wells initiated with CD34' CD38' contained BFU-E/MK based on these criteria, which represented 0.3% to 1% of normal marrow CD34' cells. By comparison, the frequency of clones containing at least three lineages and thought to originate from standard CFU-GEMM was 4.4% in the CD34' CD38' and 1% in the initial CD34' cell fraction. Despite the fact that these numbers might be underestimated, as only clones containing >l00 cells were analyzed by flow cytometry at day 12, they were in agreement with frequencies of BFU-E/MK calculated from colony assays. Finally, it remains to be determined whether some lineage markers (especially CD41 as suggested by a recent report15) could be expressed on E/MK progenitors. Our preliminary results do not favor this hypothesis as the CD34' CD41' cell population was essentially enriched in MK progenitor^.^^
In vitro appraisal of the real potential of progenitors is hampered by two difficulties. The first pertains to the fact that specific culture conditions and cytokine combinations that optimally support the differentiation of progenitor cells committed to one lineage may be inhibitory for progenitor cells committed to other lineages. Thus, myeloid and B lymphoid differentiations in long-term cultures require conditions that are mutually exclusive, but this is also true in colony assays where IL-3 has recently been shown to inhibit the emergence of B220+ cells in colonies." In this study, bipotent E/MK progenitors were not detected in the standard conditions of methylcellulose colony assays optimized for the growth of primitive BFU-E, ie, 30% FCS plus SCF, IL-3, and Epo. In the presence of FCS, the addition of MS-5 stromal cell line was absolutely required for the growth of E/MK progenitor and CFU-MK and no combination of cytokines could replace these stromal cells. In contrast, when normal plasma or AP were substituted for FCS, MS-5 cells improved terminal MK differentiation but had no significant effect on the number of MK and E/MK colonies. The inhibitory activity present in serum that inhibits MK gr~wth",".~' is most likely accounted for by TGF-p.23,40.4' Two potential mechanisms, which might act in concert, may be hypothesized to explain the effect of MS-5 cells: (1) adsorption of inhibitory molecules on proteoglycans synthesized by stromal cells may result in their neutralization, a mechanism well documented for TGF-p42; (2) alternatively, stromal cells may secrete cytokines able to counteract this suppressive effect as recently reported for bFGF.43 Whether this is accounted for by MGDF is as yet unclear; recent experiments showed that MS-5, which has reported for other stromal cells,@ synthesizes low amounts of MGDF (F. Wendling, manuscript in preparation). However, exogenous MGDF added to colony assays with 30% FCS in the absence of MS-S supported the growth neither of BFU-ENK nor CFU-MK. In serum-free plasma clot assays, MGDF alone optimally recruited CFU-MK but could not replace SCF or IL-3 in the E/MK progenitor assay. This, together with the observation that addition of MGDF to the combination of SCF, IL-3, and Epo increased the cloning efficiency of E/ MK progenitors suggests that optimal development of E/MK progenitors requires combinations of cytokines that probably act sequentially on progenitors at different maturation stages. Further experiments will be required to characterize MS-Sderived molecules that affect MK maturation.
Two additional parameters may lead to underestimation of the real potential of progenitors in culture: asynchrony in the acquisition of specific differentiation markers identifying commitment to different lineages during the course of clone formation and discrepancy in the number of cells representative of each lineage.5 For example, emergence of lymphoid cells in colonies grown from iymphohematopoietic progenitor in the mouse is a very late event.45 Three arguments, however, rule out that E M K clones were in fact multilineage For personal use only. on October 3, 2017. by guest www.bloodjournal.org From clones: (1) a similar phenotype was observed in clones that were sequentially studied at days 12 and 18; (2) time course studies in methylcellulose colony assays indicated that E/MK and CFU-GEMM represent two successive nonoverlapping waves of progenitor cells; (3) the sensitivity of immunolabeling of individual colonies, which allows the recognition of one to two MK cells within a colony.
Recent advances in the characterization of molecules associated with commitment to E and MK differentiation also strengthen the hypothesis of a tight linkage between both lineages. Expression of several transcription factors such as GATA-I, Tal-l, and NFE-2 is primarily found in both linotal role for expression of both E and MK genes." However. recent experiments suggesting that GATA-1 is only required during the late stages of the E differentiation4' and the lack of a major defect in megakaryocytopoiesis in GATA-I knock-out mice,'" question the real requirement of GATA-1 expression for early E and MK development. Whether GATA-I has an inductive role in the commitment of pluripotent stem cells as recently suggested in an avian cell line" or if its lineage-specific effects may be reiated to its restricted pattern of e~p r e s s i o n "~~~~~~ is still an unsolved question. Our results suggest that in the near future, it may be possible to have access to cellular models that directly allow us to address these questions in specific cell subpopulations.
Such an assay, which allows simultaneous identification of a high number of bipotent progenitors as well as their monopotent progeny, will also be useful to characterize growth requirements of each compartment, with particular emphasis on the response to Epo and MGDF. The E and MK lineages are the only two hematopoietic cell lineages that are regulated by humoral factors (Epo and Mpl-L/TPO/ MGDF), the level of which is regulated by the mature cell mas^.'^-^'' Several lines of evidence suggest that the Epo-R is expressed on M K " and conversely it cannot be excluded that the Mpl-R is present on a subset of E progenitors." However, preliminary attempts to identify Epo-R and Mpl-R on BFU-EMK progenitors by flow cytometry have failed (data not shown), but this does not exclude the possibility that E M K progenitors express both the Epo-R and Mpl-R at very low, albeit biologically active, levels.
eages,l?,14,16.17,4~~U and at least in vitro, GATA-I plays a piv-
NOTE ADDED IN PROOF
After acceptance of this report, a report also demonstrating the existence of bipotent E and NK progenitors was published." 
